XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

Stock Information for ToughBuilt Industries Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ToughBuilt Industries Inc.

XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements
XOMA Royalty to Present at Investor Conferences in March

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.